The absence of PRDM2 involved the tumorigenesis of somatotroph adenomas through regulating c-Myc
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China (81502389)
- National Natural Science Foundation of China (2015-3-040)
This publication has 33 references indexed in Scilit:
- PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathwayOncotarget, 2015
- The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomasBiomaterials, 2015
- A fine balance: epigenetic control of cellular quiescence by the tumor suppressor PRDM2/RIZ at a bivalent domain in the cyclin a geneNucleic Acids Research, 2015
- Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomasBMC Cancer, 2015
- A survey of tools for the analysis of quantitative PCR (qPCR) dataBiomolecular Detection and Quantification, 2014
- The interaction of MYC with the trithorax protein ASH2L promotes gene transcription by regulating H3K27 modificationNucleic Acids Research, 2014
- Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomasOncogene, 2012
- Pathogenesis of pituitary tumorsNature Reviews Endocrinology, 2011
- Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modificationsJournal of Hepatology, 2010
- Cell cycle control of pituitary development and diseaseJournal of Molecular Endocrinology, 2008